Barinthus Biotherapeutics (BRNS) Interest Expenses (2020 - 2026)
Barinthus Biotherapeutics (BRNS) reported Interest Expenses of $13000.0 for Q1 2026, little changed on a YoY basis from $13000.0 in Q1 2025, and little changed quarter-over-quarter from $13000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Interest Expenses (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics has reported Interest Expenses for 7 years, with the latest figure at $13000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses changed 0.0% year-over-year to $13000.0; the trailing twelve-month figure through Mar 2026 stood at $51000.0 (down 5.56% YoY), and the FY2025 full-year result was $51000.0, down 3.77% from the prior year.
- Interest Expenses for Q1 2026 stood at $13000.0, roughly flat from $13000.0 in the prior quarter.
- The five-year high for Interest Expenses was $74000.0 in Q1 2022, with the low at $7000.0 in Q3 2023.
- Historically, Interest Expenses has averaged $16846.2 across 5 years, with a median of $13000.0 in 2025.
- Annual changes were most pronounced in 2022 — Interest Expenses plunged 97.21% — and 2024, when it jumped 142.86%.
- Barinthus Biotherapeutics' Interest Expenses stood at $74000.0 in 2022, then sank by 90.54% to $7000.0 in 2023, then soared by 71.43% to $12000.0 in 2024, then climbed by 8.33% to $13000.0 in 2025, then changed by 0.0% to $13000.0 in 2026.
- The last three Interest Expenses figures came in at $13000.0 (Q1 2026), $13000.0 (Q4 2025), and $13000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -5.58 Mn |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | 13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |